Skip to main content
. 2020 Mar 21;26(11):1128–1141. doi: 10.3748/wjg.v26.i11.1128

Table 5.

Indications of surgery for pancreatic cysts

Absolute indications of surgery Relative indications of surgery
European guidelines[28] Intraductal papillary mucinous neoplasm: Cytology positive for malignancy/High-grade dysplasia; Solid mass; Jaundice; Mural nodule ≥ 5 mm; Main pancreatic duct dilation > 10 mm Cyst growth rate > 5 mm/yr
Mucinous cystic neoplasm: Size ≥ 4 cm Serum CA 19-9 > 37 U/mL
Symptomatic Mural nodule MPD dilation 5-9 mm
Cyst diameter ≥ 40 mm
New-onset diabetes mellitus
Acute pancreatitis related to IPMN
Mural nodule < 5 mm
American College of Gastroenterology guidelines[30] Intraductal papillary mucinous neoplasm or Mucinous cystic neoplasm: N/A
Referral to EUS-FNA/Multidisciplinary; team:
Jaundice
Acute pancreatitis
Significantly elevated CA 19-9
Mural nodule
A solid component in cyst/pancreatic parenchyma
MPD > 5 mm
Focal dilation of PD or MD-IPMN
HGD/Pancreatic cancer on cytology
American Gastroenterology Association guidelines[31] Pancreatic cysts: N/A
EUS-FNA cytology positive for -
HGD/cancer
Both solid component and dilated PD on MRI and EUS
Revised IAP 2017 or revised Fukuoka guidelines[32] Obstructive jaundice with pancreatic head cyst Pancreatitis
Enhancing mural nodule ≥ 5 mm Enhancing mural nodule < 5 mm
MPD ≥ 10 mm Thickened/enhancing cyst wall
Main duct size 5-9 mm
An abrupt change in caliber of the pancreatic duct with distal pancreatic atrophy
Lymphadenopathy
Increase in serum level of CA 19-9
Cyst growth rate ≥ 5 mm/2 yr
American College of Radiology guideline[33] Obstructive jaundice with a cyst in the head of the pancreas Cyst ≥ 3 cm
Enhancing solid component within a cyst Thickened/enhancing cyst wall
MPD > 10 mm in the absence of obstruction Non-enhancing mural nodule
MPD ≥ 7 mm

IPMN: Intraductal papillary mucinous neoplasm; HGD: High-grade dysplasia; MPD Main pancreatic duct; PD: Pancreatic duct; EUS-FNA: Endoscopic ultrasound-Fine needle aspiration.